ID   HOP-18
AC   CVCL_H642
SY   HOP 18; Hop 18; HOP18; Hop18; Hopkins-18
DR   BioSample; SAMN03472883
DR   ChEMBL-Cells; CHEMBL3307783
DR   ChEMBL-Targets; CHEMBL614809
DR   GEO; GSM206506
DR   GEO; GSM274801
DR   GEO; GSM274802
DR   NCI-DTP; HOP-18
DR   PubChem_Cell_line; CVCL_H642
DR   Wikidata; Q54890153
RX   CelloPub=CLPUB00545;
RX   PubMed=2041050;
RX   PubMed=2388294;
RX   PubMed=2536293;
RX   PubMed=25877200;
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 18,19
ST   D5S818: 9,11
ST   D7S820: 9,11
ST   D8S1179: 11,12
ST   FGA: 23,25
ST   Penta D: 13
ST   Penta E: 13
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 14
//
RX   CelloPub=CLPUB00545;
RA   McLemore T.L., Alley M.C., Liu M.C., Hubbard W.C., Adelberg S.,
RA   Czerwinski M.J., Yu S., Stinson S., Storeng R., Eggleston J.C.,
RA   Boyd M.R.;
RT   "Histopathologic, biochemical, and molecular genetic characterization
RT   of four newly established pulmonary carcinoma cell lines.";
RL   Proc. Am. Assoc. Cancer Res. 30:225-225(1989).
//
RX   PubMed=2041050; DOI=10.1093/jnci/83.11.757;
RA   Monks A., Scudiero D.A., Skehan P., Shoemaker R.H., Paull K.D.,
RA   Vistica D.T., Hose C.D., Langley J., Cronise P., Vaigro-Wolff A.,
RA   Gray-Goodrich M., Campbell H., Mayo J.G., Boyd M.R.;
RT   "Feasibility of a high-flux anticancer drug screen using a diverse
RT   panel of cultured human tumor cell lines.";
RL   J. Natl. Cancer Inst. 83:757-766(1991).
//
RX   PubMed=2388294; DOI=10.1093/jnci/82.17.1420;
RA   McLemore T.L., Litterst C.L., Coudert B.P., Liu M.C., Hubbard W.C.,
RA   Adelberg S., Czerwinski M.J., McMahon N.A., Eggleston J.C., Boyd M.R.;
RT   "Metabolic activation of 4-ipomeanol in human lung, primary pulmonary
RT   carcinomas, and established human pulmonary carcinoma cell lines.";
RL   J. Natl. Cancer Inst. 82:1420-1426(1990).
//
RX   PubMed=2536293;
RA   Hubbard W.C., Alley M.C., Gray G.N., Green K.C., McLemore T.L.,
RA   Boyd M.R.;
RT   "Evidence for prostanoid biosynthesis as a biochemical feature of
RT   certain subclasses of non-small cell carcinomas of the lung as
RT   determined in established cell lines derived from human lung tumors.";
RL   Cancer Res. 49:826-832(1989).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M.,
RA   Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S.,
RA   Neve R.M.;
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//